146 related articles for article (PubMed ID: 12750369)
1. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation.
Boren J; Lee WN; Bassilian S; Centelles JJ; Lim S; Ahmed S; Boros LG; Cascante M
J Biol Chem; 2003 Aug; 278(31):28395-402. PubMed ID: 12750369
[TBL] [Abstract][Full Text] [Related]
2. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.
Blouin JM; Penot G; Collinet M; Nacfer M; Forest C; Laurent-Puig P; Coumoul X; Barouki R; Benelli C; Bortoli S
Int J Cancer; 2011 Jun; 128(11):2591-601. PubMed ID: 20715114
[TBL] [Abstract][Full Text] [Related]
3. Butyrate metabolism upstream and downstream acetyl-CoA synthesis and growth control of human colon carcinoma cells.
Leschelle X; Delpal S; Goubern M; Blottière HM; Blachier F
Eur J Biochem; 2000 Nov; 267(21):6435-42. PubMed ID: 11029587
[TBL] [Abstract][Full Text] [Related]
4. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources.
Singh B; Halestrap AP; Paraskeva C
Carcinogenesis; 1997 Jun; 18(6):1265-70. PubMed ID: 9214612
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate.
Iacomino G; Tecce MF; Grimaldi C; Tosto M; Russo GL
Biochem Biophys Res Commun; 2001 Aug; 285(5):1280-9. PubMed ID: 11478796
[TBL] [Abstract][Full Text] [Related]
6. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29.
Gamet L; Daviaud D; Denis-Pouxviel C; Remesy C; Murat JC
Int J Cancer; 1992 Sep; 52(2):286-9. PubMed ID: 1521915
[TBL] [Abstract][Full Text] [Related]
7. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.
Alcarraz-Vizán G; Sánchez-Tena S; Moyer MP; Cascante M
Biochim Biophys Acta; 2014 Jun; 1840(6):1634-9. PubMed ID: 24368265
[TBL] [Abstract][Full Text] [Related]
8. Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells.
Domokos M; Jakus J; Szeker K; Csizinszky R; Csiko G; Neogrady Z; Csordas A; Galfi P
Dig Dis Sci; 2010 Apr; 55(4):920-30. PubMed ID: 19434493
[TBL] [Abstract][Full Text] [Related]
9. Sulphide-induced energy deficiency in colonic cells is prevented by glucose but not by butyrate.
Hulin SJ; Singh S; Chapman MA; Allan A; Langman MJ; Eggo MC
Aliment Pharmacol Ther; 2002 Feb; 16(2):325-31. PubMed ID: 11860416
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5.
Guzmán-Aránguez A; Olmo N; Turnay J; Lecona E; Pérez-Ramos P; López de Silanes I; Lizarbe MA
J Cell Biochem; 2005 Jan; 94(1):178-93. PubMed ID: 15526283
[TBL] [Abstract][Full Text] [Related]
11. Butyrate Alters Pyruvate Flux and Induces Lipid Accumulation in Cultured Colonocytes.
Bekebrede AF; Deuren TV; Gerrits WJJ; Keijer J; Boer VCJ
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681598
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
[TBL] [Abstract][Full Text] [Related]
13. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy.
Galons JP; Fantini J; Vion-Dury J; Cozzone PJ; Canioni P
Biochimie; 1989 Aug; 71(8):949-61. PubMed ID: 2553131
[TBL] [Abstract][Full Text] [Related]
15. In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells.
Olmo N; Turnay J; Pérez-Ramos P; Lecona E; Barrasa JI; López de Silanes I; Lizarbe MA
Toxicol In Vitro; 2007 Mar; 21(2):262-70. PubMed ID: 17084582
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
[TBL] [Abstract][Full Text] [Related]
17. Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate.
Stokrová J; Sloncová E; Sovová V; Kucerová D; Zíla V; Turecková J; Vojtechová M; Korb J; Tuhácková Z
Int J Oncol; 2006 Feb; 28(2):559-65. PubMed ID: 16391813
[TBL] [Abstract][Full Text] [Related]
18. Butyrate metabolism in human colon carcinoma cells: implications concerning its growth-inhibitory effect.
Andriamihaja M; Chaumontet C; Tome D; Blachier F
J Cell Physiol; 2009 Jan; 218(1):58-65. PubMed ID: 18767040
[TBL] [Abstract][Full Text] [Related]
19. Response of HT29 cells to butyrate depends on time of exposure and glucose deprivation.
Kucerová D; Stokrová J; Korb J; Sloncová E; Tuhácková Z; Sovová V
Int J Mol Med; 2002 Dec; 10(6):779-84. PubMed ID: 12430007
[TBL] [Abstract][Full Text] [Related]
20. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs.
Hofmanová J; Vaculová A; Koubková Z; Hýzd'alová M; Kozubík A
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S102-13. PubMed ID: 19156717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
